EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Palmoplantar pustulosis: pathogenesis, differential diagnosis, and treatment

Rotraut Mössner iD, Tanja Fetter, Robert Sabat, Ulrich Mrowietz iD, Neda Cramer, Dagmar Wilsmann-Theis iD

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2026

DOI: 10.1111/ddg.70238x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2026. Verfasst von Rotraut Mössner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Psoriasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Palmoplantar pustulosis (PPP) is a chronic inflammatory and often painful disease characterized by sterile pustules on the palms and soles, significantly impairing quality of life. Women are more frequently affected than men, and smoking is a major trigger. Under biologic therapies, especially TNF antagonists, a paradoxical PPP may occur. PPP is associated with psoriasis vulgaris and may be accompanied by osteoarticular involvement. Pathogenetically, PPP likely begins around the acrosyringium, with the pustules consisting almost exclusively of infiltrating neutrophilic granulocytes attracted by chemotactic factors secreted by activated keratinocytes. Inflammation is sustained through a self‐amplifying cytokine network, including interleukin (IL)‐17, IL‐19, and related mediators. Treatment options for PPP include topical treatments, UV‐phototherapies ‐ particularly topical PUVA (Psoralen plus UVA) therapy‐ and systemic therapies. Systemic agents comprise conventional treatments such as acitretin, methotrexate, fumaric acid esters, and ciclosporin, newer small molecules like apremilast and Janus kinase inhibitors, as well as biologics. Conventional systemic therapies are often not sufficiently effective in PPP and associated with side effects. Currently, among systemic therapies, only acitretin is approved for PPP. In recent years, placebo‐controlled studies have demonstrated a significant effect of apremilast, brodalumab, guselkumab and risankizumab on PPP, and further studies with topical and systemic Janus kinase inhibitors as well as IL‐17A/F inhibitors are underway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisHumansDiagnosis, DifferentialPUVA TherapyDermatologic AgentsFemale

Stichwörter der Autor:innen

PAOSAPHOpalmoplantar pustular psoriasispalmoplantar pustulosispustulosis palmoplantartherapy

Substanzen

Dermatologic Agents

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
  • Center for Skin Diseases, Department of Dermatology and Allergology, University Hospital Bonn, Bonn, Germany.
  • Translational Skin Inflammation Research, Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Be…
  • Center for Inflammatory Skin Diseases, Department of Dermatology, Venereology and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.

ORCID-Profile: Rotraut Mössner, Ulrich Mrowietz, Dagmar Wilsmann-Theis

Förderung

  • University of Bonn
  • Rheinische Friedrich-Wilhelms-Universität Bonn

Zitieren

APA

Mössner, R., Fetter, T., Sabat, R., Mrowietz, U., Cramer, N., & Wilsmann-Theis, D. (2026). Palmoplantar pustulosis: pathogenesis, differential diagnosis, and treatment. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.70238x

Vancouver

Mössner R, Fetter T, Sabat R, Mrowietz U, Cramer N, Wilsmann-Theis D. Palmoplantar pustulosis: pathogenesis, differential diagnosis, and treatment. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2026. doi:10.1111/ddg.70238x

BibTeX
@article{Mssner2026,
  author = {Mössner, Rotraut and Fetter, Tanja and Sabat, Robert and Mrowietz, Ulrich and Cramer, Neda and Wilsmann-Theis, Dagmar},
  title = {Palmoplantar pustulosis: pathogenesis, differential diagnosis, and treatment},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2026},
  doi = {10.1111/ddg.70238x}
}
Kostenlos starten →